We used PC-3 (PTEN null) and DU 145 (PTEN haploinsufficient) human prostate cancer cell lines [21] and human umbilical vein endothelial cells (HuVECs) for the analysis. This evidence concerns the gene PTEN and Familial prostate cancer.